The use of SSAP13 Accounting for Research and Development to capitalise development costs is increasing but it brings its own problems, according to Edinburgh-based accounts monitor Company Reporting.
SSAP13 is becoming a more popular choice for the capitalisation of developments costs because of its less rigorous criteria compared to FRS10 on good will and intangible assets.
But the monitor also warned the statement leads to companies having to make decisions without the aid of a comprehensive definition of an intangible fixed asset.
City analysts have yet to say whether they agree with the treatment.
The numbers you crunch tell a story. Your expertis...
26yEmbracing user-friendly AP systems can turn the tide, streamlining workflows, enhancing compliance, and opening doors to early payment discounts. Read...
View articleOrganisations can enhance their financial operations' efficiency, accuracy, and responsiveness by adopting platforms that offer them self-service cust...
View articleIn a world of instant results and automated workloads, the potential for AP to drive insights and transform results is enormous. But, if you’re still ...
View resourceDiscover how AP dashboards can transform your business by enhancing efficiency and accuracy in tracking key metrics, as revealed by the latest insight...
View articleArtificial intelligence is no longer a futuristic concept but a present-day reality. As a result, the UK government is taking proactive steps to ensur...
View articleThe UK’s Pensions Regulator (TPR) has unveiled updated guidance for superfunds, introducing pivotal changes that accountants and financial plann...
View articleSue Perkins knows more than XBRL than expected. Xero’s CEO likes to get at least 80g of protein a day, which is hard since she’s a vegetar...
View articleDo your clients see you as an expense? In fact, do you see yourself as an expense to your clients? This shift requires a fundamental change in how acc...
View articleNearly eight in ten brokers (77%) believe that high street banks are scaling back their willingness to fund small and medium-sized businesses, accordi...
View articlePharma and life sciences companies should act now to prevent impact on drug production capabilities and business viability Read More...
View article476,000 UK SMEs will need an ESG plan in the next few years. Is your firm ready to support them? Read More...
View articleGlobal spend on accountancy outsourcing up by 40% in the space of five years. News comes as accountancy outsourcing specialist AdvanceTrack reports en...
View article